VTGN
Price:
$4.1363
Market Cap:
$135.56M
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also compris...[Read more]
Industry
Biotechnology
IPO Date
2011-06-21
Stock Exchange
NASDAQ
Ticker
VTGN
According to VistaGen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of VistaGen Therapeutics, Inc. over the last ten years is 2.72%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), VTGN's Dividend Yield was at its highest in in the March 2020 quarter at 4.64%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.
Average
2.72%
Median
570.11%
Minimum
0%
Maximum
8.52%
Discovering the peaks and valleys of VistaGen Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 8.52%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | -100.00% |
| 2022 | 384.98% | -49.03% |
| 2021 | 755.24% | -88.46% |
| 2020 | 6.55% | 118.16% |
| 2019 | 3.00% | -62.38% |
| 2018 | 7.98% | -6.32% |
| 2017 | 8.52% | Infinity% |
| 2016 | 0% | 0% |
The current Dividend Yield of VistaGen Therapeutics, Inc. (VTGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
228.04%
10-year avg
2.72%
VistaGen Therapeutics, Inc.’s Dividend Yield is less than Spero Therapeutics, Inc. (0%), less than Seer, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than Opus Genetics, Inc. (0%), less than Cognition Therapeutics, Inc. (0%), less than TuHURA Biosciences, Inc. (0%), less than Agenus Inc. (0%), less than Actuate Therapeutics Inc (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Inovio Pharmaceuticals, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $129.00M | |
| 0% | $108.24M | |
| 0% | $155.52M | |
| 0% | $152.35M | |
| 0% | $124.72M | |
| 0% | $101.53M | |
| 0% | $135.44M | |
| 0% | $174.56M | |
| 0% | $119.94M | |
| 0% | $108.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VistaGen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VistaGen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is VistaGen Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for VistaGen Therapeutics, Inc. (VTGN)?
What is the highest Dividend Yield for VistaGen Therapeutics, Inc. (VTGN)?
What is the 3-year average Dividend Yield for VistaGen Therapeutics, Inc. (VTGN)?
What is the 5-year average Dividend Yield for VistaGen Therapeutics, Inc. (VTGN)?
How does the current Dividend Yield for VistaGen Therapeutics, Inc. (VTGN) compare to its historical average?